« Previous
Next »
American Journal of Kidney Diseases
Volume 52, Issue 2
, Pages 314-323
, August 2008
Cognitive-Behavioral Therapy for Sleep Disturbance in Patients Undergoing Peritoneal Dialysis: A Pilot Randomized Controlled Trial
References
- . Diagnosis and management of insomnia in dialysis patients. Semin Dial. 2006;19:25–31
- . Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant. 2004;19:95–99
- Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant. 2005;20:571–577
- Restless legs symptoms among incident dialysis patients: Association with lower quality of life and shorter survival. Am J Kidney Dis. 2004;43:900–909
- . Benefit-risk assessment of zaleplon in the treatment of insomnia. Drug Saf. 2005;28:301–318
- . Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev. 2003;CD003161
- . Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005;23:6083–6096
- . Cognitive behavior therapy and pharmacotherapy for insomnia: A randomized controlled trial and direct comparison. Arch Intern Med. 2004;164:1888–1896
- . The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213
- . Cytokines and sleep. Sleep Med Rev. 2005;9:355–364
- . Interleukin-18 promotes sleep in rabbits and rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R828–R838
- Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients. Nephrology (Carlton). 2005;10:330–335
- . Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: Immunologic effects. J Clin Oncol. 2005;23:6097–6106
- . Perceived benefits in a behavioral-medicine insomnia program: A clinical report. Am J Med. 1996;100:212–216
- . The Fatigue Severity Scale (Application to patients with multiple sclerosis and systemic lupus erythematosus). Arch Neurol. 1989;46:1121–1123
- . Measuring fatigue in patients with Parkinson's disease—The Fatigue Severity Scale. Eur J Neurol. 2002;9:595–600
- Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 2005;14:1943–1952
- Tai chi and self-rated quality of sleep and daytime sleepiness in older adults: A randomized controlled trial. J Am Geriatr Soc. 2004;52:892–900
- Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: A randomized controlled trial. JAMA. 2006;295:2851–2858
- . Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. JAMA. 2001;285:1856–1864
- Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients. Nephrol Dial Transplant. 2007;22:3606–3609
- . Ten-year trends in the pharmacological treatment of insomnia. Sleep. 1999;22:371–375
- Social relationships, sleep quality, and interleukin-6 in aging women. Proc Natl Acad Sci U S A. 2005;102:18757–18762
- . Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100:2253–2260
- . Fatigue in systemic lupus erythematosus: A randomized controlled trial of exercise. Rheumatology (Oxford). 2003;42:1050–1054
- State-specific asymmetries in EEG slow wave activity induced by local application of TNFalpha. Brain Res. 2004;1009:129–136
- . Muramyl dipeptide and IL-1 effects on sleep and brain temperature after inhibition of serotonin synthesis. Am J Physiol. 1997;273:R1663–R1668
- Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol. 1997;17:253–261
- . Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005;12:255–269
- Increased circulating interleukin-18 in patients with congestive heart failure. Heart. 2002;88:296–297
Originally published online as doi:10.1053/j.ajkd.2008.03.012 on May 23, 2008.Trial registration: http://clinicaltrials.gov; study number: NCT00155441.
PII: S0272-6386(08)00590-8
doi: 10.1053/j.ajkd.2008.03.012
© 2008 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 52, Issue 2
, Pages 314-323
, August 2008
